Promoting multinational clinical research in Europe
EuroTimes
Published: Thursday, September 8, 2016
Prof Jose Cunha-Vaz addressing the European Vision Clinical Research symposium
These are exciting times in the field of retinal research, with a significant number of European-based projects and clinical trials helping to advance current understanding of a broad range of retinal pathologies, according to several speakers at the European Vision Clinical Research Symposium on Clinical Research in Retinal Diseases.
“We believe strongly that many of the developments in ophthalmology which made EURETINA grow from over 300 participants to over 5,000 today are mainly because we now have treatments options for our patients,” said Prof Jose Cunha-Vaz, who chaired the session yesterday at the 16th EURETINA Congress in Copenhagen.
“These treatment alternatives have to be tested and evaluated, and for this we need the commitment of industry and physicians and we also need high-quality clinical trials,” he added.
Latest Articles
Addressing Postoperative Visual Complications
Managing aberrations after laser refractive surgery requires a multi-layered approach.
3D Printing Helps Transform Ukrainian Eye Care
The country’s ophthalmologists offer valuable experience in treating ocular trauma and prosthesis design.
Winning Essay Says ‘Collective Desire’ Must Drive DEI Implementation
Emerging Microbial Trends That Could Affect Your Practices
A triptych of challenges paints a concerning picture for ophthalmologists across the globe.
Improving Outcomes with Laser-Assisted Surgery
Femtosecond laser offers a multifunctional tool for improving the safety and efficacy of cataract and refractive lens exchange procedures.
Could the Corneal Transplant Pool Increase?
Modifying or discarding major contraindications for keratoplasty could mean more patients have their sight restored.
Matching Premium IOLs to Visual Lifestyles
From monofocal to full-range solutions, each practice needs comprehensive understanding.
Going Dutch on Acanthamoeba Keratitis
A world-first trial suggests a new medication could beat the disease.
Avoiding Intracorneal Ring Segment Complications
Femtosecond lasers are helping improve refractive results with fewer problems.